Cargando…

Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications

Systemic sclerosis (SSc; scleroderma) is characterized by life-threatening progressive multiorgan fibrosis orchestrated by profibrotic myofibroblasts originating from different sources. Because recent data demonstrated that the majority of myofibroblasts in a murine scleroderma model arise from adip...

Descripción completa

Detalles Bibliográficos
Autores principales: Manetti, Mirko, Romano, Eloisa, Rosa, Irene, Fioretto, Bianca Saveria, Praino, Emanuela, Guiducci, Serena, Iannone, Florenzo, Ibba-Manneschi, Lidia, Matucci-Cerinic, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723717/
https://www.ncbi.nlm.nih.gov/pubmed/31430950
http://dx.doi.org/10.3390/jcm8081256
_version_ 1783448835109945344
author Manetti, Mirko
Romano, Eloisa
Rosa, Irene
Fioretto, Bianca Saveria
Praino, Emanuela
Guiducci, Serena
Iannone, Florenzo
Ibba-Manneschi, Lidia
Matucci-Cerinic, Marco
author_facet Manetti, Mirko
Romano, Eloisa
Rosa, Irene
Fioretto, Bianca Saveria
Praino, Emanuela
Guiducci, Serena
Iannone, Florenzo
Ibba-Manneschi, Lidia
Matucci-Cerinic, Marco
author_sort Manetti, Mirko
collection PubMed
description Systemic sclerosis (SSc; scleroderma) is characterized by life-threatening progressive multiorgan fibrosis orchestrated by profibrotic myofibroblasts originating from different sources. Because recent data demonstrated that the majority of myofibroblasts in a murine scleroderma model arise from adipocytic progenitors through the adipocyte-myofibroblast transition process, we sought to determine whether the SSc microenvironment may affect the differentiation potential of adipose-derived stem cells (ADSC). Normal human ADSC from three donors were treated with serum from SSc patients (n = 6), serum from healthy individuals (n = 6), or recombinant human transforming growth factor-β1 (TGFβ1) as positive control of myofibroblastic phenotype induction. ADSC were subjected to in vitro adipogenic differentiation for up to 21 days in the presence of different stimuli followed by lipid content quantification. In selected experiments, adipocytic and mesenchymal/myofibroblast marker gene and protein expression levels were assessed by Real-Time PCR, immunoblotting and immunofluorescence after administration of different stimuli for 72 and 96 h, respectively. Cell contractile phenotype was assayed by collagen gel contraction assay. Likewise stimulation with TGFβ1, SSc serum was able to significantly inhibit the adipocyte differentiation of ADSC as testified by a strong decrease in red-colored lipid droplets after 21 days of adipogenic induction. Treatment of ADSC either with SSc serum or TGFβ1 resulted in the acquisition of a myofibroblast-like phenotype characterized by a reduced expression of the adipocytic markers perilipin and adiponectin, a significant upregulation of the mesenchymal/myofibroblast markers α-SMA+ stress fibers, S100A4 and type I collagen, and an ability to effectively contract collagen gels. In SSc, the pathologic environment may favor the differentiation of ADSC into profibrotic and contractile myofibroblast-like cells. These findings strengthen the notion that the generation of myofibroblasts from ADSC may be relevant in SSc pathophysiology potentially representing a new target for the prevention/treatment of multiorgan fibrosis.
format Online
Article
Text
id pubmed-6723717
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67237172019-09-10 Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications Manetti, Mirko Romano, Eloisa Rosa, Irene Fioretto, Bianca Saveria Praino, Emanuela Guiducci, Serena Iannone, Florenzo Ibba-Manneschi, Lidia Matucci-Cerinic, Marco J Clin Med Article Systemic sclerosis (SSc; scleroderma) is characterized by life-threatening progressive multiorgan fibrosis orchestrated by profibrotic myofibroblasts originating from different sources. Because recent data demonstrated that the majority of myofibroblasts in a murine scleroderma model arise from adipocytic progenitors through the adipocyte-myofibroblast transition process, we sought to determine whether the SSc microenvironment may affect the differentiation potential of adipose-derived stem cells (ADSC). Normal human ADSC from three donors were treated with serum from SSc patients (n = 6), serum from healthy individuals (n = 6), or recombinant human transforming growth factor-β1 (TGFβ1) as positive control of myofibroblastic phenotype induction. ADSC were subjected to in vitro adipogenic differentiation for up to 21 days in the presence of different stimuli followed by lipid content quantification. In selected experiments, adipocytic and mesenchymal/myofibroblast marker gene and protein expression levels were assessed by Real-Time PCR, immunoblotting and immunofluorescence after administration of different stimuli for 72 and 96 h, respectively. Cell contractile phenotype was assayed by collagen gel contraction assay. Likewise stimulation with TGFβ1, SSc serum was able to significantly inhibit the adipocyte differentiation of ADSC as testified by a strong decrease in red-colored lipid droplets after 21 days of adipogenic induction. Treatment of ADSC either with SSc serum or TGFβ1 resulted in the acquisition of a myofibroblast-like phenotype characterized by a reduced expression of the adipocytic markers perilipin and adiponectin, a significant upregulation of the mesenchymal/myofibroblast markers α-SMA+ stress fibers, S100A4 and type I collagen, and an ability to effectively contract collagen gels. In SSc, the pathologic environment may favor the differentiation of ADSC into profibrotic and contractile myofibroblast-like cells. These findings strengthen the notion that the generation of myofibroblasts from ADSC may be relevant in SSc pathophysiology potentially representing a new target for the prevention/treatment of multiorgan fibrosis. MDPI 2019-08-19 /pmc/articles/PMC6723717/ /pubmed/31430950 http://dx.doi.org/10.3390/jcm8081256 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Manetti, Mirko
Romano, Eloisa
Rosa, Irene
Fioretto, Bianca Saveria
Praino, Emanuela
Guiducci, Serena
Iannone, Florenzo
Ibba-Manneschi, Lidia
Matucci-Cerinic, Marco
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications
title Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications
title_full Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications
title_fullStr Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications
title_full_unstemmed Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications
title_short Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications
title_sort systemic sclerosis serum steers the differentiation of adipose-derived stem cells toward profibrotic myofibroblasts: pathophysiologic implications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723717/
https://www.ncbi.nlm.nih.gov/pubmed/31430950
http://dx.doi.org/10.3390/jcm8081256
work_keys_str_mv AT manettimirko systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications
AT romanoeloisa systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications
AT rosairene systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications
AT fiorettobiancasaveria systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications
AT prainoemanuela systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications
AT guiducciserena systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications
AT iannoneflorenzo systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications
AT ibbamanneschilidia systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications
AT matuccicerinicmarco systemicsclerosisserumsteersthedifferentiationofadiposederivedstemcellstowardprofibroticmyofibroblastspathophysiologicimplications